Sign In

Email Address:

Password:

Forgot password?

New User?

Register for Mayo Medical Laboratories

Contact Us

United States, Canada

International

Reference Laboratory Services for
Health Care Organizations

Featured Stories

The Challenges of Testing For and Diagnosing Porphyrias March 5

The Challenges of Testing For and Diagnosing Porphyrias [Communiqué]The porphyrias are a group of inborn errors of metabolism caused by enzymatic defects in the heme biosynthetic pathway. Depending upon the specific type of porphyria suspected, certain tests are more informative than other assays. Ordering a battery of tests does not enhance the quality of patient care. Rather, a stepwise diagnostic approach is the most effective means of ruling in or out a specific porphyria.

Read this story

Mayo Clinic Releases PathWays: New Online “Case Study” Tool for Pathologists and Medical Enthusiasts March 3

Mayo Clinic Releases PathWays: New Online “Case Study” Tool for Pathologists and Medical EnthusiastsMayo Medical Laboratories and Mayo Clinic’s Laboratory Medicine and Pathology Graduate Medical Education Office have developed Mayo Clinic PathWays, an online learning tool for pathologists and for those who enjoy learning about medicine. Practical case studies will be posted weekly to the Mayo Medical Laboratories blog for medical professionals around the world.

Read this story

Register Now for Diagnostic Molecular Pathology Conference March 2

Register Now for  Diagnostic Molecular Pathology ConferenceRegistration is now open for the Diagnostic Molecular Pathology conference. The two-day conference will be held from April 13-14 in Rochester, Minnesota.

Read this story

HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma: Indication, Interpretation, and Implication March 2

HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma: Indication, Interpretation, and Implication [Hot Topic]Human papillomavirus (HPV) is regarded as a causative agent in the majority of oropharyngeal squamous cell carcinoma cases. For this reason, HPV and p16 testing are used to determine prognosis and treatment strategies for these patients. Dr. Joaquín García describes the various HPV and p16 testing platforms and respective performance characteristics as they relate to clinical management.

Read this story


Key